raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:182090

Pulmonary arterial hypertension

Synonyms: PAH

Type
Category
Group
Group of disorders
Inheritance
Autosomal dominant, Not applicable
Age of onset
All ages
Status
active

Pulmonary arterial hypertension (PAH) is a group of diseases characterized by elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, or induced by drug or toxin (drug-or toxin-induced PAH) or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPulmonary arterial hypertensionPAH
frHypertension artérielle pulmonaireHTAP
dePulmonale arterielle Hypertonie
esHipertensión arterial pulmonarHAP
itIpertensione arteriosa polmonare= en
nlPulmonale arteriële hypertensie= en
ptHipertensão arterial pulmonar
plTętnicze nadciśnienie płucne= en
csPlicní arteriální hypertenze= en
ukЛегенева артеріальна гіпертензія= en
zh肺动脉高压= en
trPulmoner arteriyel hipertansiyon= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-11BB01.0Especificvalidated
MONDO0015924Evalidated
MONDO15924Evalidated
MeSHD000081029Evalidated
UMLSC2973725Evalidated
GARD7501Evalidated
MedDRA10064911Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

Children (3):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

12 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0002 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2018[OTHER]_16456139[PMID]_17360728[PMID]
Point prevalence1-9 / 100 0001.6 / 100 000SpainValue and classValidated22362843[PMID]
Annual incidence1-9 / 1 000 0000.37 / 100 000SpainValue and classValidated22362843[PMID]
Point prevalence1-9 / 100 0001.5 / 100 000FranceValue and classValidated16456139[PMID]
Annual incidence1-9 / 1 000 0000.24 / 100 000FranceValue and classValidated16456139[PMID]
Point prevalence1-9 / 100 0001.09 / 100 000United StatesValue and classValidated21793646[PMID]
Annual incidence1-9 / 100 0001.07 / 100 000Czech RepublicValue and classValidated24629043[PMID]
Point prevalence1-9 / 100 0002.24 / 100 000Czech RepublicValue and classValidated24629043[PMID]
Point prevalence1-9 / 100 0001.55 / 100 000SwitzerlandValue and classValidated18587690[PMID]
Annual incidence1-9 / 1 000 0000.35 / 100 000SwitzerlandValue and classValidated18587690[PMID]
Annual incidence1-9 / 1 000 0000.72 / 100 000United KingdomValue and classValidated21885399[PMID]_17360728[PMID]
Point prevalence1-9 / 100 0005.2 / 100 000United KingdomValue and classValidated17360728[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card